Tipiracil NEW
Price | $59 |
Package | 2mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: Tipiracil | CAS No.: 183204-74-2 |
Supply Ability: 10g | Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | Tipiracil |
Description | Tipiracil is an inhibitor of thymidine phosphorylase(TPase). |
In vitro | Tipiracil functions as a thymidine phosphorylase inhibitor, enhancing trifluridine's efficacy by impeding its metabolism via thymidine phosphorylase. This synergistic action facilitates the use of the Trifluridine-Tipiracil combination as an innovative oral treatment for metastatic colorectal cancer [2]. Additionally, Tipiracil fortifies the stability of FTD by mitigating its first-pass degradation through its inhibitory action on thymidine phosphorylase [3]. |
Storage | Shipping with blue ice. |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$43.00/5mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/1Kg/Bag |
VIP4Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-07-16 | |
$0.00/5mg |
Simson Pharma limited
|
2022-07-29 | ||
$1.00/1g |
VIP5Y
|
Career Henan Chemica Co
|
2020-11-12 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hills
INQUIRY